How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?

How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?

Introduction: We aimed to investigate the effects of the coronavirus disease 2019 (COVID-19) pandemic on the course and treatment of patients with inflammatory rheumatic musculoskeletal disease (iRMD) using biologic or targeted synthetic disease modifying and rheumatic drugs (b/tsDMARDs). Methodo...

Full description

Saved in:
Bibliographic Details
Main Authors: Semih Gulle, Yesim Erez, Ali Karakas, Tuba Yuce Inel, Sinem Burcu Kocaer, Tuba Demirci Yildirim, Gercek Can, Ismail Sari, Merih Birlik, Fatos Onen
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2023-07-01
Series:Journal of Infection in Developing Countries
Subjects:
COVID-19
SARS-COV-2
pandemic
rheumatology
biologic therapy
b/tsDMARD
Online Access:https://jidc.org/index.php/journal/article/view/17470
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/17470

Similar Items